Suppliers / Wuhan Zy Pharmaceutical

Wuhan Zy Pharmaceutical

China Updated 9 July 2026

Wuhan Zy Pharmaceutical is an API manufacturer based in China. It holds 7 active US drug master files across a filed portfolio of 5 molecules.

7
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Posaconazole US FDA 2
Tigecycline US FDA 2
Ezetimibe US FDA 1
Ticagrelor US FDA 1
Voriconazole US FDA 1

Also appears on these molecule pages

Posaconazole API Tigecycline API Ezetimibe API Ticagrelor API Voriconazole API

Questions about Wuhan Zy Pharmaceutical

Does Wuhan Zy Pharmaceutical hold a US DMF or a CEP?
Wuhan Zy Pharmaceutical holds 7 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Wuhan Zy Pharmaceutical make?
5 molecules are on record against Wuhan Zy Pharmaceutical, including Posaconazole, Tigecycline, Ezetimibe and Ticagrelor. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Wuhan Zy Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Olon shares 2 molecules MSN Laboratories shares 1 molecule Dr Reddy's Laboratories shares 1 molecule Neuland Laboratories shares 1 molecule Cohance Lifesciences shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability